European Medicines Agency's (EMA) Committee for Orphan Medicinal Products has announced positive opinion for granting orphan disease designation to Aspireo Pharmaceuticals' Somatoprim for the treatment of acromegaly. Somatoprim, the ...
The European Medicines Agency (EMA) has granted orphan drug status to AlphaCore Pharma's ACP-501 (rhLCAT) to treat familial LCAT deficiency (FLD). FLD causes lipid deposition in eyes, red blood cells and kidneys which can lead to corneal ...
Tags: EMA, orphan drug status, AlphaCore FLD
Scientific testing by an independent laboratory has proven that a specialized laundering process, offered by UniFirst Corporation and used to disinfect and protect food industry garments, destroys pathogens known to cause nearly 90 million ...
Tags: garment, food industry garments, uniforms
The European Medicines Agency (EMA) has accepted to review the Dynavax Technologies Marketing Authorization Application (MAA) for Heplisav. Heplisav is indicated for immunization against infection caused by all known subtypes of hepatitis ...
Astellas Pharma and Medivation have announced the submission of marketing authorization application (MAA) to the European Medicines Agency (EMA) for enzalutamide to treat metastatic castration-resistant prostate cancer in men who have ...
Tags: enzalutamide, metastatic castration-resistant prostate cancer
Ireland/UK-Irish Lighting rental company Production Services Ireland(PSI)became fully embroiled in the weekend commemorating the centenary of the sinking of the world's most famous cruise ship-Titanic. The ship-the largest afloat at ...
Janssen Research & Development has announced that it has submitted a supplemental New Drug Application to FDA for ZYTIGA(abiraterone acetate). Janssen-Cilag International NV has also sent a type II variation to the European Medicines ...
The Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has recommended Orphan Drug Designation (ODD) for Erytech Pharma's investigational product Enhoxy. The drug, which is used to treat sickle cell ...
Tags: orphan drug designation, Erytech product, debilitating disease
Ligand Pharmaceuticals partner GlaxoSmithKline has submitted regulatory applications in the US and European Union for the use of eltrombopag (Promacta/Revolade) to increase platelet counts in patients with hepatitis C. A supplemental ...
UK-Stage Crew,the Belfast based crewing company,have been kept exceptionally busy recently with a whole host of Titanic related events in Northern Ireland. The Titanic Festival kicked off in early April with a spectacular light and ...
Tags: Titanic, Northern Ireland, concert, Culture Creative
Arno Therapeutics has received orphan-drug designation for AR-42 to treat neurofibromatosis type 2 (NF2) in the Europe. AR-42 is a broad-spectrum deacetylation inhibitor of both histone and non-histone proteins. The orally ...
Tags: Orphan-Drug designation, inhibitor, AR-42, clinical product
Raptor Pharmaceutical has submitted a new drug application (NDA) to the FDA for marketing approval of Cysteamine Bitartrate delayed-release capsules (RP103), to treat nephropathic cystinosis. Raptor has appealed for priority review of ...
Tags: clinical trial, pharmaceutical product, new drug application
A national research study conducted by Eric Mower + Associates' Contractor Insight specialty reveals that contractors make nearly half of their tool and building supply purchases from big-box retailers. "Retailers score high for variety and ...
Tags: Market View, DIYer, contractor